Peer Support Program for Quitting Vaping
(V2V Trial)
Trial Summary
What is the purpose of this trial?
The dramatic increase in the use of e-cigarettes among U.S. adolescents has been called a national epidemic, with more adolescents now using e-cigarettes than traditional cigarettes. The high amounts of nicotine in e-cigarettes harm adolescents and put them at greater risk of becoming traditional cigarette smokers. The investigators propose to develop Vaper-to-Vaper (V2V), a suite of mobile peer driven tools including peer texting and coaching based on lessons learned in the investigators' prior tobacco intervention work, to engage and help adolescents use strategies to manage cravings and successfully quit.
Research Team
Rajani Sadasivam, PhD
Principal Investigator
University of Massachusetts Chan Medical School
Lori Pbert, PhD
Principal Investigator
University of Massachusetts Chan Medical School
Eligibility Criteria
This trial is for high school students in grades 9-12 who currently use e-cigarettes and can communicate in English or Spanish. Participants must have used an e-cigarette at least once in the past week and own a smartphone. Those unable to give informed consent or assent are excluded.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- E-Cigarette Cessation Materials
- Gamification
- Peer Coaching via Text
- Peer Messaging
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Massachusetts, Worcester
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator